Expand SPRB Menu
SPRB MENU

SPRB Latest Press Releases

-- March 9, 2026 --

Spruce Biosciences Reports Full Year 2025 Financial Results and Provides Corporate Updates Business Wire 7:05 AM
Spruce Biosciences Appoints Dale Hooks, an Accomplished Rare Disease Commercial Leader, as Chief Commercial Officer Business Wire 7:00 AM

-- March 2, 2026 --

Spruce Biosciences to Present at Upcoming Investor Conferences in March Business Wire 4:05 PM

-- February 18, 2026 --

Spruce Biosciences Announces Positive Type B Meetings with U.S. FDA for TA-ERT for the Treatment of Sanfilippo Syndrome Type B (MPS IIIB) Business Wire 7:00 AM

-- February 17, 2026 --

Spruce Biosciences to Participate in the Oppenheimer 36th Annual Healthcare Life Sciences Conference Business Wire 4:05 PM

-- February 5, 2026 --

Long-Term Data Presented at the 22nd Annual WORLDSymposium Highlights Tralesinidase Alfa Enzyme Replacement Therapy's Potential as the First Disease-Modifying Treatment Option for Sanfilippo Syndrome Type B (MPS IIIB) Business Wire 4:05 PM

-- February 3, 2026 --

Spruce Biosciences Adds Regulatory and Clinical Development Expertise to Leadership Team Business Wire 8:00 AM

-- January 28, 2026 --

Spruce Biosciences Announces Data Presentations at the 22nd Annual WORLDSymposium Business Wire 8:00 AM

-- January 18, 2026 --

Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration PRNewswire 7:03 PM

-- January 8, 2026 --

Spruce Biosciences Secures Up to $50 Million in Growth Capital from Avenue Capital Business Wire 8:00 AM

-- December 15, 2025 --

Spruce Biosciences Appoints Proven Pharmaceutical Commercial Leader Keli Walbert to Board of Directors Business Wire 8:00 AM
Market Data Delayed 15 Minutes